JP2024510975A5 - - Google Patents
Info
- Publication number
- JP2024510975A5 JP2024510975A5 JP2023555527A JP2023555527A JP2024510975A5 JP 2024510975 A5 JP2024510975 A5 JP 2024510975A5 JP 2023555527 A JP2023555527 A JP 2023555527A JP 2023555527 A JP2023555527 A JP 2023555527A JP 2024510975 A5 JP2024510975 A5 JP 2024510975A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- prostate cancer
- approximately
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163160319P | 2021-03-12 | 2021-03-12 | |
| US63/160,319 | 2021-03-12 | ||
| PCT/US2022/019662 WO2022192481A1 (en) | 2021-03-12 | 2022-03-10 | Methods of treating prostate cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024510975A JP2024510975A (ja) | 2024-03-12 |
| JP2024510975A5 true JP2024510975A5 (https=) | 2025-03-18 |
Family
ID=80952117
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023555527A Pending JP2024510975A (ja) | 2021-03-12 | 2022-03-10 | 前立腺癌を処置する方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12016847B2 (https=) |
| EP (1) | EP4304589A1 (https=) |
| JP (1) | JP2024510975A (https=) |
| KR (1) | KR20230156107A (https=) |
| CN (1) | CN117241797A (https=) |
| WO (1) | WO2022192481A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CR20220630A (es) | 2020-05-09 | 2023-01-23 | Arvinas Operations Inc | Métodos para fabricar un compuesto bifuncional, formas ultrapuras del compuesto bifuncional y formas de dosificación que comprenden el mismo |
| TW202535392A (zh) | 2023-12-08 | 2025-09-16 | 美商亞文納營運公司 | 使用雄性素受體降解劑治療脊髓延髓性肌肉萎縮 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI477503B (zh) | 2008-10-31 | 2015-03-21 | Medivation Technologies Inc | 含有剛性部分之吡啶并〔４，３－ｂ〕吲哚 |
| CN102257076B (zh) | 2008-12-18 | 2014-07-30 | 纳幕尔杜邦公司 | 具有新颜料的粉末涂料组合物 |
| US8580399B2 (en) | 2011-04-08 | 2013-11-12 | Universal Display Corporation | Substituted oligoazacarbazoles for light emitting diodes |
| WO2013046635A1 (ja) | 2011-09-28 | 2013-04-04 | 出光興産株式会社 | 有機エレクトロルミネッセンス素子用材料及びそれを用いた有機エレクトロルミネッセンス素子 |
| UA115576C2 (uk) | 2012-12-06 | 2017-11-27 | Байєр Фарма Акцієнгезелльшафт | Похідні бензимідазолу як антагоністи ер4 |
| EP2961747B1 (en) | 2013-02-27 | 2017-11-15 | Bristol-Myers Squibb Company | Carbazole compounds useful as bromodomain inhibitors |
| US9492460B2 (en) | 2013-02-27 | 2016-11-15 | Bristol-Myers Squibb Company | Carbazole compounds useful as bromodomain inhibitors |
| EP2970312B1 (en) | 2013-03-11 | 2017-11-15 | The Regents of The University of Michigan | Bet bromodomain inhibitors and therapeutic methods using the same |
| KR102457145B1 (ko) * | 2013-12-24 | 2022-10-19 | 브리스톨-마이어스 스큅 컴퍼니 | 항암제로서의 트리시클릭 화합물 |
| US9458156B2 (en) * | 2014-12-23 | 2016-10-04 | Bristol-Myers Squibb Company | Tricyclic compounds as anticancer agents |
| WO2015131005A1 (en) * | 2014-02-28 | 2015-09-03 | The Regents Of The University Of Michigan | 9h-pyrimido[4,5-b]indoles and related analogs as bet bromodomain inhibitors |
| AU2015358334A1 (en) * | 2014-12-05 | 2017-06-08 | Dana-Farber Cancer Institute, Inc. | Bromodomain inhibitor as adjuvant in cancer immunotherapy |
| WO2017216772A2 (en) * | 2016-06-16 | 2017-12-21 | The University Of Chicago | Methods and compositions for treating breast and prostate cancer |
| WO2019080941A1 (en) | 2017-10-27 | 2019-05-02 | Jacobio-Beta Pharmaceuticals Co., Ltd. | NEW TRICYCLIC COMPOUNDS |
| WO2021175432A1 (en) | 2020-03-04 | 2021-09-10 | Boehringer Ingelheim International Gmbh | Method for administration of an anti cancer agent |
-
2022
- 2022-03-07 US US17/653,717 patent/US12016847B2/en active Active
- 2022-03-10 WO PCT/US2022/019662 patent/WO2022192481A1/en not_active Ceased
- 2022-03-10 KR KR1020237034510A patent/KR20230156107A/ko active Pending
- 2022-03-10 JP JP2023555527A patent/JP2024510975A/ja active Pending
- 2022-03-10 CN CN202280032513.3A patent/CN117241797A/zh active Pending
- 2022-03-10 EP EP22713194.3A patent/EP4304589A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024510975A5 (https=) | ||
| JP2020519295A5 (https=) | ||
| JP2016528162A5 (https=) | ||
| JP2023500483A5 (https=) | ||
| JP2022542238A5 (https=) | ||
| FI2547205T3 (fi) | Uusia menetelmiä syövän kantasolujen kohdentamiseksi | |
| RU2018137037A (ru) | Антинеопластические комбинации, содержащие hki-272 и винорелбин | |
| JP2009215293A5 (https=) | ||
| Jin | Arsenic trioxide: an ancient drug revived | |
| JP2016527202A5 (https=) | ||
| JP2023522716A5 (https=) | ||
| Jiang et al. | Intervention of mirtazapine on gemcitabine-induced mild cachexia in nude mice with pancreatic carcinoma xenografts | |
| JP2022501383A5 (https=) | ||
| JP2019112416A5 (https=) | ||
| JP2024516359A5 (https=) | ||
| JP2023102786A5 (https=) | ||
| Chatterjee et al. | Application of Ayurvedic Bhasma for the treatment of cancer | |
| JP2016502540A5 (https=) | ||
| JP6433686B2 (ja) | 癌治療用組成物の調製のためのイカリチンの使用 | |
| CN110314149B (zh) | 一种聚普瑞锌片及其制备工艺 | |
| WO2022207648A1 (en) | A pi3k-delta inhibitor for the treatment of pancreatic cancer | |
| CN101757623B (zh) | 一种5-ht受体激动剂固体药物组合物 | |
| TW202143973A (zh) | 用於治療ＰＲＣ２介導的疾病或障礙的Ｎ—（（５—氟—２，３—二氫苯并呋喃—４—基）甲基）—８—（２—甲基吡啶—３—基）—［１，２，４］三唑并［４，３—ｃ］嘧啶—５—胺或其藥學上可接受的鹽之給藥方案 | |
| JP7174370B2 (ja) | 予後改善剤 | |
| Pramanik et al. | Neutropenia due to palbociclib: A word of caution? |